Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.56B | 1.41B | 986.30M | 563.80M | 421.00M | 302.60M |
Gross Profit | 1.26B | 1.10B | 638.20M | 369.10M | 260.50M | 188.10M |
EBITDA | 575.40M | 520.00M | 166.90M | 62.90M | 60.90M | 35.60M |
Net Income | 431.30M | 354.60M | 114.00M | 32.90M | 30.90M | 15.00M |
Balance Sheet | ||||||
Total Assets | 16.51B | 15.14B | 11.90B | 7.56B | 4.30B | 2.38B |
Cash, Cash Equivalents and Short-Term Investments | 1.06B | 1.06B | 11.48B | 7.25B | 1.62B | 2.19B |
Total Debt | 52.40M | 224.20M | 249.90M | 78.50M | 78.60M | 49.20M |
Total Liabilities | 15.34B | 14.16B | 11.33B | 7.16B | 4.02B | 2.18B |
Stockholders Equity | 1.17B | 979.90M | 576.90M | 409.20M | 285.30M | 196.80M |
Cash Flow | ||||||
Free Cash Flow | 3.49B | 3.24B | 3.91B | 3.13B | 2.05B | 1.17B |
Operating Cash Flow | 3.51B | 3.25B | 3.92B | 3.14B | 2.07B | 1.19B |
Investing Cash Flow | 250.00M | -142.60M | -2.59B | -490.40M | -671.80M | -20.90M |
Financing Cash Flow | -372.30M | -125.60M | 153.90M | -1.30M | 24.80M | 31.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £13.10B | 25.46 | 35.22% | ― | 34.39% | 94.35% | |
69 Neutral | ¥229.24B | 14.26 | 7.64% | 2.72% | 9.14% | 8.60% | |
67 Neutral | £2.40B | 14.80 | 19.50% | 4.14% | 0.61% | -9.17% | |
65 Neutral | £237.78M | 11.58 | 28.48% | 5.75% | -22.84% | -49.60% | |
62 Neutral | £3.30B | 26.35 | 47.63% | 0.54% | 10.75% | 10.61% | |
57 Neutral | £195.60M | 315.38 | 1.06% | 3.87% | 3.57% | ― | |
56 Neutral | £541.25M | ― | -11.89% | ― | -22.83% | -350.82% |